Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020-Reference-Cited by-同舟云学术

Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020

Published:2021-05-12 Issue: Volume: Page:
ISSN:1424-3997
Container-title:Swiss Medical Weekly
language:en
Short-container-title:Swiss Med Wkly

Author:

Ortland Imke¹,Mirjalili Mahtabalsadat²,Kullak-Ublick Gerd A.¹,Peymani Payam³

Affiliation:

1. Department of Clinical Pharmacology and Toxicology, University Hospital Zurich (USZ), University of Zurich (UZH), Switzerland

2. Department of Clinical Pharmacy, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

3. Department of Clinical Pharmacology and Toxicology, University Hospital Zurich (USZ), University of Zurich (UZH), Switzerland / Health Policy Research Centre, Institute of Heath, Shiraz University of Medical Sciences, Shiraz, Iran

Publisher

EMH Swiss Medical Publishers, Ltd.

Subject

General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil extracellular traps promote acetaminophen-induced acute liver injury in mice via AIM2;Acta Pharmacologica Sinica;2024-04-08

2. Integrating network pharmacology and drug side-effect data to explore mechanism of liver injury-induced by tyrosine kinase inhibitors;Computers in Biology and Medicine;2024-01

3. Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease;Expert Opinion on Drug Metabolism & Toxicology;2023-05-04

4. DILIrank dataset for QSAR modeling of drug-induced liver injury;QSAR in Safety Evaluation and Risk Assessment;2023

5. A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI Registry;Liver International;2022-08-15